← FDA Drug Approvals (Drugs@FDA)

OZURDEX

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2009-06-17

Drug application

FDA Application #

NDA022315

Application type

New Drug Application

Brand name

OZURDEX

Generic name

DEXAMETHASONE

Active ingredients

DEXAMETHASONE

Dosage form

IMPLANT

Route

INTRAVITREAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2009-06-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown